Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
Top Cited Papers
- 1 February 2009
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 122 (2) , S3-S13
- https://doi.org/10.1016/j.amjmed.2008.12.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Reduced Fracture Rates Observed Only in Patients With Proper Persistence and Compliance With Bisphosphonate TherapiesSouthern Medical Journal, 2007
- Loss of treatment benefit due to low compliance with bisphosphonate therapyOsteoporosis International, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- Economic Burden of Osteoporosis-Related Fractures in MedicaidValue in Health, 2007
- A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosisCurrent Medical Research and Opinion, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study*International Journal Of Clinical Practice, 2006
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006